Lv1
10 积分 2024-02-28 加入
Hepatic arterial infusion chemotherapy versus transarterial chemoembolization, potential conversion therapies for single huge hepatocellular carcinoma: a retrospective comparison study
2天前
已完结
Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody
4天前
已完结
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
5天前
已完结
Post-TACE FDG Accumulation in HCC Surrounding the Liver Parenchyma
5天前
已完结
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
5天前
已完结
TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma
5天前
已完结
Final analysis of serum biomarkers in patients (pts) from the phase III study of lenvatinib (LEN) vs sorafenib (SOR) in unresectable hepatocellular carcinoma (uHCC) [REFLECT]
15天前
已完结
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
15天前
已完结
Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy
20天前
已完结
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
2个月前
已完结
皖公网安备34019202002308
